[144] KESTRA MEDICAL TECHNOLOGIES, LTD. SEC Filing

Rhea-AI Filing Summary

Kestra Medical Technologies notice of proposed resale: a reporting holder filed a Rule 144 notice to sell 15,000 restricted common shares granted under the issuer's equity compensation plan on 01/21/2026. The filing lists three prior sales by the same holder: 15,000 shares on 02/17/2026 for $384,020.06, 15,000 shares on 03/17/2026 for $304,123.49, and 15,000 shares on 04/15/2026 for $300,671.04.

Insights

Securities Counsel

Rule 144 notice filed for resale of restricted shares; prior open-market sales recorded.

The filing records a 15,000-share restricted issuance dated 01/21/2026 under the company's equity compensation plan and a Rule 144 notice to sell that allotment. It also documents three prior sales by the same holder in 02/2026, 03/2026, and 04/2026 with explicit sale proceeds.

Timing and exact resale mechanics beyond the listed dates are not stated in the excerpt; cash‑flow treatment and broker involvement are shown only by the broker address line. Subsequent filings may disclose completion details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	15000	314329.85	58373353	05/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	01/21/2026	Restricted share issuance	KESTRA MEDICAL TECHNOLOGIES, LTD.			15000	01/21/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Webster 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Shares	02/17/2026	15000	384020.06
Brian Webster 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Shares	03/17/2026	15000	304123.49
Brian Webster 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Shares	04/15/2026	15000	300671.04

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)